FASN and cancer: Elevated glucose catabolism is a characteristic of many cancers, and produces an excess of the glycolytic end-product, pyruvate, some of which can be converted to acetyl-CoA and then further converted, through an FASN mediated pathway, to fatty acids43,44 (Fig. 2e).